Home
>
US Stocks
>
Blueprint Medicines Corp
Blueprint Medicines Corp
BPMC

Blueprint Medicines Corp

$103.7511.97%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
101.8
Today Low/High
101.52 / 103.75
52 Week Low/High
$66.2 / $125.61
P/E ratio
16.23
Market Cap
$5.52B

Company Details

Blueprint Medicines is a global precision therapy company that invents life-changing medicines for people with cancer and hematologic disorders. Applying an approach that is both precise and agile, the company creates therapies that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, Blueprint has leveraged its research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, the company is delivering its approved medicines to patients in the United States and Europe, and the company is globally advancing multiple programs for genomically defined cancers, systemic mastocytosis, and cancer immunotherapy.
Organisation
Blueprint Medicines Corp
Headquaters
Cambridge, Massachusetts, US
Employees
429
Industry
Health Technology
CEO
Jeffrey Albers

Discover more

Frequently Asked Questions

What is Blueprint Medicines Corp share price today

Can Indians buy Blueprint Medicines Corp shares?

How can I buy Blueprint Medicines Corp shares from India?

Can Fractional shares of Blueprint Medicines Corp be purchased?

What are the documents required to start investing in Blueprint Medicines Corp stocks?

We are a SEBI registered investement advisor